Angiotensin metabolism in rat stomach wall: Prevalence of angiotensin-1-7 formation

Journal of Physiology and Pharmacology

Volumn 60, Issue 1, 2009, Pages 191-196

  Olszanecki, Rafal ^a,b   Madej, J ^a   Suski, M ^a   Gebska, A ^a   Bujak Gizycka, B ^a   Korbut, R ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Department of Pharmacology ^*  (Poland)

Author keywords

ACE inhibitors (ACEi); Angiotensin converting enzyme (ACE); Angiotensin (1 7); Gastric angiotensin metabolism; Gastroprotection

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL RAT; HORMONE METABOLISM; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PREVALENCE; RAT; RENAL ARTERY; STOMACH WALL;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION REGULATION; INDOLES; MALE; NEPRILYSIN; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED WKY; RENAL ARTERY; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STOMACH; THIORPHAN;

EID: 65949091144     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bernstein KE. Views of the renin-angiotensin system: brilling, mimsy, and slithy tove. Hypertension 2006; 47(3): 509-514.
2. Ferrario CM, Chappell MC. Novel angiotensin peptides. Cell Mol Life Sci 2004; 61(21): 2720-2727.
3. Varagic J, Trask AJ, Jessup JA, Chappell MC, Ferrario CM. New angiotensins. J Mol Med 2008; 86(6): 663-671.
4. Kramkowski K, Mogielnicki A, Buczko W. The physiological significance of the alternative pathways of angiotensin II production. J Physiol Pharmacol 2006; 57(4): 529-539.
5. Lee MA, Bohm M, Paul M, Ganten D. Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation 1993; 87(5 Suppl): IV 7-IV 13.
6. Miyazaki M, Takai S. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J Pharmacol Sci 2006; 100(5): 391-397.
7. Paul M, Poyan MA, Kreutz R. Physiology of local reninangiotensin systems. Physiol Rev 2006; 86(3): 747-803.
8. Wolf G. Novel aspects of the renin-angiotensin-aldosterone-system. Front Biosci 2008; 13: 4993-5005.
9. Nonotte I, Laliberte MF, Duperray C, Hollande F, Bali JP, Laliberte F et al. Expression of angiotensin I converting enzyme mRNA in rabbit gastric epithelial cells. Mol Cell Endocrinol 1993; 92(2):167-174.
10. Nonotte I, Laliberte MF, Gannoun-Zaki L, Bali JP, Chevillard C, Laliberte F. Localization of angiotensin-converting enzyme (ACE) mRNA in rabbit gastric mucosa by in situ hybridization. J Histochem Cytochem 1994; 42(2):197-201.
11. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004; 203(2): 631-637.
12. Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM. Angiotensin II AT1 receptor blockade prevents gastric ulcers during cold-restraint stress. Ann N Y Acad Sci 2004; 1018: 351-355.
13. Cullen JJ, Ephgrave KS, Kleiman-Wexler RL, Broadhurst K. Angiotensin-converting enzyme inhibition, kinins, and stress ulceration. Curr Surg 1990; 47(6): 452-454.
14. Ender F, Labancz T, Rosivall L. Protective effects of the inhibition of the renin-angiotensin system against gastric mucosal lesions induced by cold-restraint in the rat. Acta Physiol Hung 1993; 81(1):13-18.
15. Kincaid EH, Miller PR, Meredith JW, Chang MC. Enalaprilat improves gut perfusion in critically injured patients. Shock 1998; 9(2): 79-83.
16. Nakagiri A, Sunamoto M, Murakami M. Angiotensin AT1 receptor blockers suppress ischemia/reperfusion-induced gastric injury in rats. Inflammopharmacology 2007; 15(4): 171-174.
17. Bujak-Gizycka B, Madej J, Wolkow PP, Olszanecki R, Drabik L, Rutowski J et al. Measurement of angiotensin metabolites in organ bath and cell culture experiments by liquid chromatography - electrospray ionization - mass spectrometry (LC-ESI-MS). J Physiol Pharmacol 2007; 58(3): 529-540.
18. Olszanecki R, Bujak-Gizycka B, Madej J, Suski M, Wolkow PP, Jawien J et al. Kaempferol, but not resveratrol inhibits angiotensin converting enzyme. J Physiol Pharmacol 2008; 59(2): 387-392.
19. Gosgnach W, Challah M, Coulet F, Michel JB, Battle T. Shear stress induces angiotensin converting enzyme expression in cultured smooth muscle cells: possible involvement of bFGF. Cardiovasc Res 2000; 45(2): 486-492.
20. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 2004; 43(5): 970-976.
21. Carpenter TC, Stenmark KR. Hypoxia decreases lung neprilysin expression and increases pulmonary vascular leak. Am J Physiol Lung Cell Mol Physiol 2001; 281(4): L941-L948.
22. Gebska A, Olszanecki R. NOS-2 induction in rat lungs after Escherichia coli lipopolisaccharide administration. Folia Med Cracov 2007; 48: 23-33.
23. Matsuo T, Ikura Y, Ohsawa M, Ogami M, Kayo S, Yoshimi N et al. Mast cell chymase expression in Helicobacter pyloriassociated gastritis. Histopathology 2003; 43(6): 538-549.
24. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006; 15(10): 1929-1934.
25. Roques BP. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme]. J Pharmacol 1985; 16 Suppl 1: 5-31.
26. Santos RA, Ferreira AJ, Simoes E Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008; 93(5): 519-527.
27. Haulica I, Bild W, Serban DN. Angiotensin peptides and their pleiotropic actions. J Renin Angiotensin Aldosterone Syst 2005; 6(3): 121-131.
28. Chappel MC, Ferrario CM. ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1- 7). Kidney Int 2006; 70(1): 8-10.
29. Chappell MC. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension 2007; 50(4): 596-599.
30. Bregonzio C, Armando I, Ando H, Jezova M, Baiardi G, Saavedra JM. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol 2003; 285(2): G414-G423.
31. Sendur R, Biernat R, Pawlik M, Obuchowicz R, Pawlik WW. Role of angiotensin 1-7 in the mediation of gastric circulatory and protective action angiotensin converting enzyme inhibitor. An annual meeting of professional research scientist: Experimental Biology 2005, 2-6 April 2005 and XXXV International Congress of Physiological Sciences March 31 - April 5, 2005, San Diego, USA, The FASEB Journal 2005; 19 (4): A74.